These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33121085)

  • 1. Luteolin Induces Selective Cell Death of Human Pluripotent Stem Cells.
    Go YH; Kim J; Jeong HC; Kim SM; Kim YJ; Park SJ; Moon SH; Cha HJ
    Biomedicines; 2020 Oct; 8(11):. PubMed ID: 33121085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of pluripotent stem cell-derived teratoma formation by small molecules.
    Lee MO; Moon SH; Jeong HC; Yi JY; Lee TH; Shim SH; Rhee YH; Lee SH; Oh SJ; Lee MY; Han MJ; Cho YS; Chung HM; Kim KS; Cha HJ
    Proc Natl Acad Sci U S A; 2013 Aug; 110(35):E3281-90. PubMed ID: 23918355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quercetin induced ROS production triggers mitochondrial cell death of human embryonic stem cells.
    Kim SY; Jeong HC; Hong SK; Lee MO; Cho SJ; Cha HJ
    Oncotarget; 2017 Sep; 8(39):64964-64973. PubMed ID: 29029404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technical approaches to induce selective cell death of pluripotent stem cells.
    Jeong HC; Cho SJ; Lee MO; Cha HJ
    Cell Mol Life Sci; 2017 Jul; 74(14):2601-2611. PubMed ID: 28246701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A massive suspension culture system with metabolic purification for human pluripotent stem cell-derived cardiomyocytes.
    Hemmi N; Tohyama S; Nakajima K; Kanazawa H; Suzuki T; Hattori F; Seki T; Kishino Y; Hirano A; Okada M; Tabei R; Ohno R; Fujita C; Haruna T; Yuasa S; Sano M; Fujita J; Fukuda K
    Stem Cells Transl Med; 2014 Dec; 3(12):1473-83. PubMed ID: 25355733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells.
    Fonoudi H; Ansari H; Abbasalizadeh S; Larijani MR; Kiani S; Hashemizadeh S; Zarchi AS; Bosman A; Blue GM; Pahlavan S; Perry M; Orr Y; Mayorchak Y; Vandenberg J; Talkhabi M; Winlaw DS; Harvey RP; Aghdami N; Baharvand H
    Stem Cells Transl Med; 2015 Dec; 4(12):1482-94. PubMed ID: 26511653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human cardiomyocyte generation from pluripotent stem cells: A state-of-art.
    Talkhabi M; Aghdami N; Baharvand H
    Life Sci; 2016 Jan; 145():98-113. PubMed ID: 26682938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Strategies and Challenges for Purification of Cardiomyocytes Derived from Human Pluripotent Stem Cells.
    Ban K; Bae S; Yoon YS
    Theranostics; 2017; 7(7):2067-2077. PubMed ID: 28638487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Passive Stretch Induces Structural and Functional Maturation of Engineered Heart Muscle as Predicted by Computational Modeling.
    Abilez OJ; Tzatzalos E; Yang H; Zhao MT; Jung G; Zöllner AM; Tiburcy M; Riegler J; Matsa E; Shukla P; Zhuge Y; Chour T; Chen VC; Burridge PW; Karakikes I; Kuhl E; Bernstein D; Couture LA; Gold JD; Zimmermann WH; Wu JC
    Stem Cells; 2018 Feb; 36(2):265-277. PubMed ID: 29086457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma-activated medium selectively eliminates undifferentiated human induced pluripotent stem cells.
    Matsumoto R; Shimizu K; Nagashima T; Tanaka H; Mizuno M; Kikkawa F; Hori M; Honda H
    Regen Ther; 2016 Dec; 5():55-63. PubMed ID: 31245502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac Regeneration with Human Pluripotent Stem Cell-Derived Cardiomyocytes.
    Park M; Yoon YS
    Korean Circ J; 2018 Nov; 48(11):974-988. PubMed ID: 30334384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lessons from the heart: mirroring electrophysiological characteristics during cardiac development to in vitro differentiation of stem cell derived cardiomyocytes.
    van den Heuvel NH; van Veen TA; Lim B; Jonsson MK
    J Mol Cell Cardiol; 2014 Feb; 67():12-25. PubMed ID: 24370890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral Vector-Based Innovative Approaches to Directly Abolishing Tumorigenic Pluripotent Stem Cells for Safer Regenerative Medicine.
    Mitsui K; Ide K; Takahashi T; Kosai KI
    Mol Ther Methods Clin Dev; 2017 Jun; 5():51-58. PubMed ID: 28480304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elimination of undifferentiated human embryonic stem cells by cardiac glycosides.
    Lin YT; Wang CK; Yang SC; Hsu SC; Lin H; Chang FP; Kuo TC; Shen CN; Chiang PM; Hsiao M; Lu FL; Lu J
    Sci Rep; 2017 Jul; 7(1):5289. PubMed ID: 28706279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of human pluripotent stem cells and pluripotent stem cell-derived cellular models for assessing drug toxicity.
    Apáti Á; Varga N; Berecz T; Erdei Z; Homolya L; Sarkadi B
    Expert Opin Drug Metab Toxicol; 2019 Jan; 15(1):61-75. PubMed ID: 30526128
    [No Abstract]   [Full Text] [Related]  

  • 16. The safety of human pluripotent stem cells in clinical treatment.
    Simonson OE; Domogatskaya A; Volchkov P; Rodin S
    Ann Med; 2015; 47(5):370-80. PubMed ID: 26140342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting differentiation potential of human pluripotent stem cells: Possibilities and challenges.
    Liu LP; Zheng YW
    World J Stem Cells; 2019 Jul; 11(7):375-382. PubMed ID: 31396366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly sensitive droplet digital PCR method for detection of residual undifferentiated cells in cardiomyocytes derived from human pluripotent stem cells.
    Kuroda T; Yasuda S; Matsuyama S; Tano K; Kusakawa S; Sawa Y; Kawamata S; Sato Y
    Regen Ther; 2015 Dec; 2():17-23. PubMed ID: 31245455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expansion Culture of Human Pluripotent Stem Cells and Production of Cardiomyocytes.
    Le MNT; Hasegawa K
    Bioengineering (Basel); 2019 May; 6(2):. PubMed ID: 31137703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conditionally replicating adenovirus prevents pluripotent stem cell-derived teratoma by specifically eliminating undifferentiated cells.
    Mitsui K; Ide K; Takayama A; Wada T; Irie R; Kosai K
    Mol Ther Methods Clin Dev; 2015; 2():15026. PubMed ID: 26269798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.